Alpha IMS

subretinal

inactive

Retina Implant AG initially produced the Alpha IMS to help those affected by retinitis pigmentosa.

Milestones

  • 2013: CE mark approval
  • 2019: End of production

Background

https://www.youtube.com/watch?v=buKTnXuq0ic&feature=emb_logo

Device Specifications

  • Electrode layout: rectilinear
  • Electrode pitch: 70 μm
  • Image processor location: subretinal